The Cooper Companies, Inc. (COO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol COO
- Company The Cooper Companies, Inc.
- Price $66.35
- Changes Percentage -2.83
- Change -1.935
- Day Low $65.68
- Day High $71.62
- Year High $112.38
- Year Low $69.81
- Market Cap $15,990,480,760
- Price Avg 50 EMA (D) $80.49
- Price Avg 200 EMA (D) $93.91
- Exchange NASDAQ
- Volume 3,811,369
- Average Volume 2,168,883
- Open $71.62
- Previous Close $68.28
- EPS 2.07
- PE 38.63
- Earnings Announcement 2025-05-29 04:00:00
- Shares Outstanding $199,981,000
Company brief: THE COOPER COMPANIES, INC. (COO )
- Healthcare
- Medical - Instruments & Supplies
- Mr. Albert G. White III
- https://www.coopercos.com
- US
- N/A
- 01-21-1983
- US2166485019
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
COO Corporation News
Understanding The Cooper Companies (COO) Reliance on International Revenue
zacks.com -- Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock....
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?
zacks.com -- Cooper Companies COO delivered a solid fiscal second quarter performance in 2025, surpassing analyst expectations with $1 billion in revenue (up 6.3% YoY) and adjusted earnings per share (EPS) of 96 c...
COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down
zacks.com -- COO's fiscal Q2 earnings and sales beat market expectations on the back of strong growth. Improvement in operating margin bodes well....
The Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript
seekingalpha.com -- The Cooper Companies, Inc. (NASDAQ:COO ) Q2 2025 Results Conference Call May 29, 2025 5:00 PM ET Company Participants Kim Duncan - Vice President, Investor Relations & Risk Management Al White - Presi...
Cooper Companies raises 2025 profit forecast on contact lens demand
reuters.com -- Cooper Companies raised its annual profit forecast on Thursday, after beating quarterly results estimates, banking on strong demand for its contact lenses....